Jonathan Chang, Ph.D., CFA
Senior Managing Director, Emerging OncologyJonathan Chang, Ph.D., CFA is a Senior Research Analyst at Leerink Partners covering Emerging Oncology.
Dr. Chang joined the Firm in 2013 and served as an Associate supporting the Firm’s senior oncology biotechnology research team. In 2016, he assumed research coverage of several important emerging biotechnology companies. In 2018, Dr. Chang was named a Rising Star in Institutional Investor’s 2018 All-America Research Team for Biotechnology/Mid- & Small-Cap.
Dr. Chang earned an Honors B.Sc. in Genes, Genetics, and Biotechnology from the University of Toronto, an M.A. in Biotechnology from Columbia University, and a Ph.D. in Pharmacology from Cornell University. Dr. Chang is a CFA charter holder.
